(Allergan plc)

	AGN latest price $298.3804 (0.16%) ($297.2512 - $301.1311) on Thu. Jun. 25, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.2% (three month average)
RSI	58
Latest Price	$298.3804(0.16%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.4% a day on average for past five trading days.
Weekly Trend	AGN advances 1.4% a week on average for past two weeks.
Market Behavior	Value stocks sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(54%)    IBB(53%)    XBI(47%)    SPY(43%)    VT(42%)
Factors Impacting AGN price	AGN will decline at least -0.6% in a week (0% probabilities).   VIXM(-31%)    TLT(-19%)    SHY(-7%)    UUP(-6%)    IGOV(-5%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.6% (StdDev 1.2%)
Hourly BBV	0 ()
Intraday Trend	-0%

5 Day Moving Average	$297.22(0.39%)
10 Day Moving Average	$293.6(1.63%)
20 Day Moving Average	$293.06(1.82%)
To recent high	-1.3%
To recent low	9.3%
Market Cap	$98.376b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed